Brief: Bergenbio ASA Reports Financial Position Of NOK 200.1 Mln End Of Q2 2024
Aug 21 (Reuters) - Bergenbio ASA BGBIO.OL :
* BERGENBIO ASA: FINANCIAL POSITION OF NOK 200.1 MILLION END
OF Q2
2024
* BERGENBIO ASA: OPERATING EXPENSES NOK 50.8 MILLION IN Q2
2024
COMPARED TO NOK 47.8 MILLION IN Q2 2023
* BERGENBIO ASA: CONTINUED DECREASED AND STABILIZED
OPERATING
EXPENSES AT NOK 90.5 MILLION FOR FIRST HALF 2024 COMPARED TO NOK
120.2 MILLION IN FIRST HALF 2023
Source text for Eikon: ID:nWkrb3CYt3
Further company coverage: BGBIO.OL
((reuters.briefs@thomsonreuters.com;))
Recent news on Oncoinvent ASA
See all newsBrief: Oncoinvent To Raise Up To NOK 140 Million In Private Placement
Brief: Oncoinvent H1 Operating Loss NOK 69 Mln
Brief: Oncoinvent Secures New Patent Expanding Protection For Radspherin
Brief: Oncoinvent's Shares To Be Consolidated In Ratio Of 100:1
Brief: Oncoinvent To Increase Share Capital In Connection With Settlement Of Underwriting Fee